Left ventricular non-compaction (LVNC) is a cardiomyopathy that can either result from arrested or abnormal myocardial morphogenesis during heart development, or can be acquired later in life. Current practice guidelines recommend different strategies for the manage- is rare. As clinical manifestations of LVNC are non-specific, particular imaging modalities (echocardiography, cardiovascular magnetic resonance imaging or ECG gated computed tomography) should be used in order to establish the diagnosis of LVNC. Antiarrhythmic drugs and implantable cardioverter defibrillators may be considered for the management of ventricular arrhythmias in patients with ventricular non-compaction. We report the presentation, diagnosis and management of a 46 year-old female with refractory severe cardiac failure, repeated syncope due to LVNC and atrial septal defect, requiring medical therapy and an implantable cardioverter defibrillator as a "life bridge" to heart transplantation.
INTRODUCTION
Left ventricular non-compaction (LVNC) is a cardiomyopathy characterized by changes in myocardial wall, caused by prominent left ventricular trabeculae and deep intertrabecular recesses [1, 2] , as well as the thickening of the myocardium into two distinct layers (compacted and not compacted) [3] [4] [5] . The first case of LVNC associated with other cardiac abnormalities was described in 1932 by Bellet and Gouley in a paper concerning an autopsy of a Left Ventricular Non-Compaction Associated with Atrial Septal Defect -a Rare Cause of Refractory Severe Cardiac Failure newborn [6] . Since then several articles and reviews have described cases of LVNC associated with other congenital heart diseases [7] [8] [9] [10] . The prevalence of this disorder in the general population has not been well established yet, ranging between 0.06 and 0.3% [7] , however other recent studies [11] demonstrate an unexpectedly high percentage (23.6%) of patients with heart failure fulfilling current echocardiographic criteria for LVNC.
We report a case of a 46 year-old woman with refractory severe heart failure and repeated syncope due to LVNC a associated with an atrial septal defect, requiring medical therapy and an implantable cardioverter defibrillator (ICD) device as a "life bridge" to an orthotopic heart transplant.
CASE PRESENTATION
A 46 year-old Caucasian woman was admitted in the hospital with a 5-year history of progressive exertional dyspnea, orthopnea and atypical chest pain. In the last 2 weeks before admission she experienced 2 episodes of palpitations associated with syncope. Previous personal medical records revealed a 5-year history of LVNC diagnosis, sequelae of a "cryptogenic" stroke (a 3 × 3.5 cm basal ganglia hypodense lesion on head CT scan) and a gastroesophageal reflux disease. A coronary angiography performed 2 years before the current presentation revealed normal coronary anatomy and flow. The family history was highly suggestive for cardiac disease and a sudden cardiac death was reported in her first degree relatives (brother deceased at age 20 from SCD, possibly associated with dilated cardiomyopathy, and a sister with LVNC). On examination she presented regular sinus rhythm with a rate of 88 beats/minute and a blood pressure of 90/60 mmHg. Cardiac auscultation revealed a diminished first and second heart sound and mild holosystolic mitral murmur. Coarse crepitations at both lung bases and a moderate hepatomegaly were also identified.
Oxygen saturation was 93% in ambient air and 99% on oxygen mask. No changes were observed in full blood count, serum electrolytes, renal and thyroid function. 
DISCUSSION
We presented the case of LVNC in a middle-aged female patient with concomitant ASD, former cerebral thromboembolism, ventricular arrhythmias and refractory heart failure, with a remarkable family history of sudden cardiac death associated with cardiomyopathies. This case is particular as it presented a progressively worsening clinical evolution (reduced EF, myocardial fibrosis on MRI, cerebral thromboembolism) and a poor prognosis in the absence of orthotopic heart transplantation.
Left ventricular non-compaction is a cardiomyopathy defined by the presence of prominent left ventricular trabeculae, deep intertrabecular recesses and thin compacted layers [13, 14] .
It can be classified as a primary genetically-determined cardiomyopathy [1] or, according to European Society of Cardiology statements, an unclassified cardiomyopathy [2] .
In the current practice familial (inherited) and nonfamilial (sporadic) cases of LVNC are described. The case MIM number refers to a numerical assignment for genes and functional segments of deoxyribonucleic acid, as well as to inherited diseases. X-linked recessive indicates that both matching genes must be abnormal to cause the disease.
ACTC1 -actin, alpha, cardiac muscle; DTNA -dystrobrevin alpha; LDB3 -Lim domain-binding 3; LVNC -left ventricular noncompaction; MIB1 -homolog of Drosophila mindbomb; MYBPC3 -myosin-binding protein C, cardiac; MYH7 -myosin heavy chain 7, cardiac muscle, beta; PRDM16 -PR domain-containing protein 16; TAZ -tafazzin; TNNT2 -troponin T2; TPM1 -tropomyosin 1.
Phenotype Mapping Key: 2 -the disorder was placed on the map by statistical methods. 3 -the molecular basis of the disorder is known [adapted after 14, 20] .
presented here is a familial one, as demonstrated by positive family history; most of the cases described in the literature are associated with mutations in the same genes that cause other cardiomyopathies such as hypertrophic, restrictive or dilated cardiomyopathy [14] [15] [16] .
Recently published data offer multiple hypotheses of etiologic bases of LVNC: it can be encountered as an isolated disease, in association with other genetic diseases and congenital defects, isolated or acquired in different conditions; some reports indicate a permanent or transient aspect of LVNC [14, [17] [18] [19] .
Human genetic studies (with inherent limitations) suggest that several genes are associated with LVNV [14] .
Embryologic morphogenetic hypotheses suggest two possibilities: arrested or abnormal myocardial morphogenesis occuring during heart development and usually affecting the left ventricle [21] or a form of LVNC resulting from inhibition of the regression of embryonic structures [9, 14] .
In the management of LVNC the following aspects should be carefully carried out: diagnosis, monitoring and treatment [14] . Table 2 presents the clinical management of LVNC.
Echocardiography is the first-line imaging tool in all settings of cases with suspected LVNC. Some echocardiographic criteria have been suggested as indicators of the disease, together with family history and genetic studies [13, [22] [23] [24] , however none of them can be considered as "gold standard" for LVNC diagnosis. For a positive diagnosis of LVNC, a non-compacted/compacted ratio >2.0 in end-systole must be identified [23] .
Cardiac magnetic resonance (CMR) is particularly useful
for differential diagnosis of LVNC from normal variants of trabeculations [25] . The cut-off value of 2.3 for the noncompacted/compacted myocardium ratio has been widely accepted for diagnosis of LVNC [26] . In our patient the non-compacted/compacted ratio was 8.5, therefore one important criterion for diagnosis was fulfilled. Additional However, only limited data exist describing the clinical outcome of patients with LVNC and implanted ICDs, and no predictors for appropriate ICD therapy are available [30] [31] [32] [33] .
In patients with LVNC, reduced ejection fraction (<35%) and signs of ventricular dyssynchronism, cardiac resynchronization therapy could be considered in order to improve NYHA functional class [34, 35] .
Patients with LVNC who have end-stage heart failure are candidates for heart transplantation, and successful orthotopic heart transplantation in LVNC patients with end-stage heart failure has been reported [9, 36] . 
